A Systematic Review of Patients' Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms
- PMID: 33461781
- DOI: 10.1016/j.eururo.2020.12.019
A Systematic Review of Patients' Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms
Abstract
Context: Understanding men's values and preferences in the context of personal, physical, emotional, relational, and social factors is important in optimising patient counselling, facilitating treatment decision-making, and improving guideline recommendations.
Objective: To systematically review the available evidence regarding the values, preferences, and expectations of men towards the investigation and treatment (conservative, pharmacological, and surgical) of male lower urinary tract symptoms (LUTS).
Evidence acquisition: We searched electronic databases until August 31, 2020 for quantitative and qualitative studies that reported values and preferences regarding the investigation and treatment of LUTS in men. We assessed the quality of evidence and risk of bias using the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) and GRADE Confidence in the Evidence from Reviews of Qualitative Research (CERQual) approaches.
Evidence synthesis: We included 25 quantitative studies, three qualitative studies, and one mixed-methods study recruiting 9235 patients. Most men reported urodynamic testing to be acceptable, despite discomfort or embarrassment, as it significantly informs treatment decisions (low certainty evidence). Men preferred conservative and less risky treatment options, but the preference varied depending on baseline symptom severity and the risk/benefit characteristics of the treatment (moderate certainty). Men preferred pharmacological treatments with a low risk of erectile dysfunction and those especially improving urgency incontinence (moderate certainty). Other important preference considerations included reducing the risk of acute urinary retention or surgery (moderate certainty).
Conclusions: Men prefer lower-risk management options that have fewer sexual side effects and are primarily effective at improving urgency incontinence and nocturia. Overall, the evidence was rated to be of low to moderate certainty. This review can facilitate the treatment decision-making process and improve the trustworthiness of guideline recommendations.
Patient summary: We thoroughly reviewed the evidence addressing men's values and preferences regarding the management of urinary symptoms and found that minimising adverse effects is particularly important. Further research to understand other factors that matter to men is required.
Keywords: Diagnostics; Evidence; Expectations; Guideline; Investigation; Lower urinary tract symptoms; Management; Patient; Treatment; Values and preferences.
Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Comment in
-
Male Lower Urinary Tract Symptoms and Benign Prostatic Obstruction: What Do Patients Want?Eur Urol. 2021 Jun;79(6):810-811. doi: 10.1016/j.eururo.2021.01.015. Epub 2021 Jan 23. Eur Urol. 2021. PMID: 33494938 No abstract available.
-
Re: Sachin Malde, Roland Umbach, Jessica R. Wheeler, et al. A Systematic Review of Patients' Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms. Eur Urol 2021;79:796-809: Benign Prostatic Hyperpalsia Surgery: Safety? Yes, Please.Eur Urol. 2021 Jun;79(6):e170-e171. doi: 10.1016/j.eururo.2021.02.036. Epub 2021 Mar 3. Eur Urol. 2021. PMID: 33674180 No abstract available.
-
Re: A Systematic Review of Patients' Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms.Eur Urol. 2021 Aug;80(2):254-255. doi: 10.1016/j.eururo.2021.04.009. Epub 2021 Apr 27. Eur Urol. 2021. PMID: 33926764 No abstract available.
-
Benign Prostatic Hyperplasia.J Urol. 2021 Oct;206(4):1038-1041. doi: 10.1097/JU.0000000000002125. Epub 2021 Jul 20. J Urol. 2021. PMID: 34281370 No abstract available.
-
Benign Prostatic Hyperplasia Treatment On Its Way to Precision Medicine: Dream or Reality?Eur Urol Focus. 2022 Mar;8(2):363-364. doi: 10.1016/j.euf.2022.03.023. Epub 2022 Apr 7. Eur Urol Focus. 2022. PMID: 35400612 No abstract available.
-
Voiding Function and Dysfunction, Bladder Physiology and Pharmacology, and Female Urology.J Urol. 2022 Oct;208(4):935-938. doi: 10.1097/JU.0000000000002878. Epub 2022 Aug 3. J Urol. 2022. PMID: 35920074 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical